This study is in progress, not accepting new patients
Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at La Jolla, California
- Dates
- study startedestimated completion
- Principal Investigator
- by Gregory Daniels, MD, PhDEzra Cohen, MD
Description
Summary
Official Title
Keywords
Eligibility
Location
Lead Scientists at UCSD
- Gregory Daniels, MD, PhD
Dr. Daniels coordinates our clinical program in melanoma. His own research involves understanding the link between autoimmunity and tumor immunity in developing more effective and less toxic vaccines and immune stimulatory approaches for patients with melanoma. - Ezra Cohen, MD
Professor, Medicine, Vc-health Sciences-schools. Authored (or co-authored) 205 research publications
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Gregory Daniels
- ID
- NCT03991741
- Phase
- Phase 1 research study
- Study Type
- Interventional
- Participants
- Expecting 24 study participants
- Last Updated